Medicinal products – List of marketing authorisations granted by the EEA EFTA States for the second half of 2018 2020/C 123/06
Date: 2020-04-16
Institutions: Standing Committee of the EFTA States
Subjects: EFTA countries, European Economic Area, free movement of goods, market approval, medicinal product, withdrawal from the market








C_2020123EN.01000601.xml










16.4.2020   


EN


Official Journal of the European Union


C 123/6






Medicinal products – List of marketing authorisations granted by the EEA EFTA States for the second half of 2018
(2020/C 123/06)

Subcommittee I on the free movement of goods


To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July – 31 December 2018, at their meeting on 29 March 2019:






Annex I


List of new marketing authorisations




Annex II


List of renewed marketing authorisations




Annex III


List of extended marketing authorisations




Annex IV


List of withdrawn marketing authorisations




Annex V


List of suspended marketing authorisations








ANNEX I
List of new marketing authorisations
The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July–31 December 2018:








EU-Number


Product


Country


Date of authorisation




EU/1/13/859


Corbilta


Liechtenstein


31.8.2018




EU/1/16/1115


Pemetrexed Fresenius Kabi


Liechtenstein


31.8.2018




EU/1/16/1138


Venclyxto (without conditions)


Liechtenstein


31.12.2018




EU/1/17/1219


Verkazia


Iceland


25.7.2018




EU/1/17/1219


Verkazia


Norway


18.9.2018




EU/1/17/1234


Tremfya


Liechtenstein


31.8.2018




EU/1/17/1246


Mvasi


Liechtenstein


31.8.2018




EU/1/17/1255


Intrarosa


Norway


21.8.2018




EU/1/18/1264


Alunbrig


Iceland


6.12.2018




EU/1/18/1264


Alunbrig


Norway


18.12.2018




EU/1/18/1264


Alunbrig


Liechtenstein


31.12.2018




EU/1/18/1273


Prasugrel Mylan


Norway


3.7.2018




EU/1/18/1275


Riarify


Norway


17.8.2018




EU/1/18/1276


Myalepta


Iceland


21.8.2018




EU/1/18/1276


Myalepta


Norway


17.8.2018




EU/1/18/1276


Myalepta


Liechtenstein


31.8.2018




EU/1/18/1278


Carmustine Obvius


Liechtenstein


31.10.2018




EU/1/18/1278


Carmustine Obvius


Iceland


17.8.2018




EU/1/18/1278


Carmustine Obvius


Norway


9.8.2018




EU/1/18/1284


Dzuveo


Iceland


2.7.2018




EU/1/18/1286


Hyrimoz


Iceland


16.8.2018




EU/1/18/1286


Hyrimoz


Norway


7.8.2018




EU/1/18/1286


Hyrimoz


Liechtenstein


31.8.2018




EU/1/18/1287


Hefiya


Iceland


20.8.2018




EU/1/18/1287


Hefiya


Norway


7.8.2018




EU/1/18/1287


Hefiya


Liechtenstein


31.8.2018




EU/1/18/1288


Halimatoz


Iceland


20.8.2018




EU/1/18/1288


Halimatoz


Norway


7.8.2018




EU/1/18/1288


Halimatoz


Liechtenstein


31.8.2018




EU/1/18/1290


Nityr


Iceland


28.8.2018




EU/1/18/1290


Nityr


Norway


17.8.2018




EU/1/18/1292


Apealea


Iceland


30.11.2018




EU/1/18/1292


Apealea


Liechtenstein


31.12.2018




EU/1/18/1293


Aimovig


Iceland


16.8.2018




EU/1/18/1293


Aimovig


Norway


7.8.2018




EU/1/18/1293


Aimovig


Liechtenstein


31.8.2018




EU/1/18/1294


Rxulti


Iceland


21.8.2018




EU/1/18/1294


Rxulti


Norway


21.8.2018




EU/1/18/1294


Rxulti


Liechtenstein


31.8.2018




EU/1/18/1295


Trazimera


Iceland


21.8.2018




EU/1/18/1295


Trazimera


Norway


7.8.2018




EU/1/18/1295


Trazimera


Liechtenstein


31.8.2018




EU/1/18/1296


Tegsedi


Iceland


25.7.2018




EU/1/18/1296


Tegsedi


Norway


6.8.2018




EU/1/18/1296


Tegsedi


Liechtenstein


31.8.2018




EU/1/18/1297


Kymriah


Iceland


21.9.2018




EU/1/18/1297


Kymriah


Norway


31.8.2018




EU/1/18/1297


Kymriah


Liechtenstein


31.10.2018




EU/1/18/1298


Veyvondi


Iceland


26.9.2018




EU/1/18/1298


VEYVONDI


Norway


25.9.2018




EU/1/18/1299


Yescarta


Iceland


21.9.2018




EU/1/18/1299


Yescarta


Norway


31.8.2018




EU/1/18/1299


Yescarta


Liechtenstein


31.10.2018




EU/1/18/1300


Duzallo


Iceland


30.8.2018




EU/1/18/1300


Duzallo


Norway


4.9.2018




EU/1/18/1300


Duzallo


Liechtenstein


31.10.2018




EU/1/18/1301


Mepsevii


Iceland


21.9.2018




EU/1/18/1301


Mepsevii


Norway


4.9.2018




EU/1/18/1302


Kigabeq


Iceland


23.10.2018




EU/1/18/1302


Kigabeq


Norway


16.10.2018




EU/1/18/1302


Kigabeq


Liechtenstein


31.10.2018




EU/1/18/1303


Udenyca


Iceland


5.11.2018




EU/1/18/1303


Udenyca


Liechtenstein


31.10.2018




EU/1/18/1305


Cablivi


Iceland


26.9.2018




EU/1/18/1305


Cablivi


Norway


25.9.2018




EU/1/18/1306


Symkevi


Iceland


13.11.2018




EU/1/18/1306


Symkevi


Norway


12.11.2018




EU/1/18/1307


Verzenios


Iceland


24.10.2018




EU/1/18/1307


Verzenios


Norway


8.10.2018




EU/1/18/1307


Verzenios


Liechtenstein


31.10.2018




EU/1/18/1308


Vyxeos


Iceland


21.9.2018




EU/1/18/1308


Vyxeos


Norway


31.8.2018




EU/1/18/1308


Vyxeos


Liechtenstein


31.10.2018




EU/1/18/1309


Ulipristal Acetate Gedeon Richter


Liechtenstein


31.8.2018




EU/1/18/1309


Ulipristal Acetate Gedeon Richter


Iceland


31.8.2018




EU/1/18/1309


Ulipristal Acetate Gedeon Richter


Norway


12.9.2018




EU/1/18/1310


Deferiprone Lipomed


Iceland


23.10.2018




EU/1/18/1310


Deferiprone Lipomed


Norway


1.10.2018




EU/1/18/1310


Deferiprone Lipomed


Liechtenstein


31.10.2018




EU/1/18/1311


Nerlynx


Iceland


26.9.2018




EU/1/18/1311


Nerlynx


Norway


21.9.2018




EU/1/18/1311


Nerlynx


Liechtenstein


31.10.2018




EU/1/18/1312


Xerava


Iceland


24.10.2018




EU/1/18/1312


Xerava


Norway


25.10.2018




EU/1/18/1313


Pelgraz


Iceland


23.10.2018




EU/1/18/1313


Pelgraz


Norway


8.10.2018




EU/1/18/1313


Pelgraz


Liechtenstein


31.10.2018




EU/1/18/1303


Udenyca


Norway


1.10.2018




EU/1/18/1314


Braftovi


Iceland


11.10.2018




EU/1/18/1314


Braftovi


Norway


25.9.2018




EU/1/18/1314


Braftovi


Liechtenstein


31.10.2018




EU/1/18/1315


Mektovi


Iceland


11.10.2018




EU/1/18/1315


Mektovi


Norway


25.9.2018




EU/1/18/1315


Mektovi


Liechtenstein


31.10.2018




EU/1/18/1316


Lenalidomide Accord


Iceland


23.10.2018




EU/1/18/1316


Lenalidomide Accord


Norway


16.10.2018




EU/1/18/1316


Lenalidomide Accord


Liechtenstein


31.10.2018




EU/1/18/1318


Slenyto


Iceland


23.10.2018




EU/1/18/1318


Slenyto


Norway


16.10.2018




EU/1/18/1318


Slenyto


Liechtenstein


31.10.2018




EU/1/18/1319


Hulio


Iceland


12.10.2018




EU/1/18/1319


Hulio


Norway


16.10.2018




EU/1/18/1319


Hulio


Liechtenstein


31.10.2018




EU/1/18/1320


Onpattro


Iceland


24.9.2018




EU/1/18/1320


Onpattro


Norway


11.9.2018




EU/1/18/1321


Gefitinib Mylan


Iceland


25.10.2018




EU/1/18/1321


Gefitinib Mylan


Norway


8.10.2018




EU/1/18/1321


Gefitinib Mylan


Liechtenstein


31.10.2018




EU/1/18/1322


Imfinzi


Iceland


23.10.2018




EU/1/18/1322


Imfinzi


Norway


8.10.2018




EU/1/18/1322


Imfinzi


Liechtenstein


31.10.2018




EU/1/18/1323


Ilumetri


Iceland


12.10.2018




EU/1/18/1323


Ilumetri


Norway


16.10.2018




EU/1/18/1323


Ilumetri


Liechtenstein


31.10.2018




EU/1/18/1324


Jivi


Iceland


6.12.2018




EU/1/18/1324


Jivi


Norway


6.12.2018




EU/1/18/1324


Jivi


Liechtenstein


31.12.2018




EU/1/18/1327


Ziextenzo


Iceland


10.12.2018




EU/1/18/1327


Ziextenzo


Norway


5.12.2018




EU/1/18/1327


Ziextenzo


Liechtenstein


31.12.2018




EU/1/18/1328


Pelmeg


Iceland


4.12.2018




EU/1/18/1328


Pelmeg


Norway


5.12.2018




EU/1/18/1328


Pelmeg


Liechtenstein


31.12.2018




EU/1/18/1329


Fulphila


Iceland


3.12.2018




EU/1/18/1329


Fulphila


Norway


5.12.2018




EU/1/18/1329


Fulphila


Liechtenstein


31.12.2018




EU/1/18/1330


Emgality


Iceland


3.12.2018




EU/1/18/1330


Emgality


Norway


30.11.2018




EU/1/18/1331


Luxturna


Iceland


11.12.2018




EU/1/18/1331


Luxturna


Norway


20.12.2018




EU/1/18/1332


Pifeltro


Iceland


5.12.2018




EU/1/18/1332


Pifeltro


Norway


13.12.2018




EU/1/18/1332


Pifeltro


Liechtenstein


31.12.2018




EU/1/18/1333


Delstrigo


Iceland


12.12.2018




EU/1/18/1333


Delstrigo


Norway


13.12.2018




EU/1/18/1333


Delstrigo


Liechtenstein


31.12.2018




EU/1/18/1334


Vabomere


Iceland


30.11.2018




EU/1/18/1334


Vabomere


Norway


13.12.2018




EU/1/18/1334


Vabomere


Liechtenstein


31.12.2018




EU/1/18/1335


Poteligeo


Iceland


6.12.2018




EU/1/18/1335


Poteligeo


Liechtenstein


31.12.2018




EU/1/18/1335


Poteligeo


Norway


18.12.2018




EU/1/18/1336


Buvidal


Iceland


3.12.2018




EU/1/18/1336


Buvidal


Norway


5.12.2018




EU/1/18/1336


Buvidal


Liechtenstein


31.12.2018




EU/1/18/1340


Takhzyro


Iceland


5.12.2018




EU/1/18/1340


TAKHZYRO


Norway


6.12.2018




EU/1/18/1340


TAKHZYRO


Liechtenstein


31.12.2018




EU/1/18/1341


Ogivri


Liechtenstein


31.12.2018




EU/1/17/1219


Verkazia


Liechtenstein


31.8.2018




EU/2/17/220


MiPet Easecto


Liechtenstein


31.8.2018




EU/2/18/227


UBAC


Iceland


11.9.2018




EU/2/18/227


UBAC


Norway


24.8.2018




EU/2/18/227


UBAC


Liechtenstein


31.8.2018




EU/2/18/230


Cortacare


Iceland


25.9.2018




EU/2/18/230


Cortacare


Norway


24.9.2018




EU/1/18/1284


Dzuveo


Norway


6.7.2018









ANNEX II
List of renewed marketing authorisations
The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July–31 December 2018:








EU-Number


Product


Country


Date of authorisation




EU/1/06/367


Diacomit


Iceland


12.10.2018




EU/1/06/367


Diacomit


Norway


16.10.2018




EU/1/06/367


Diacomit


Liechtenstein


31.10.2018




EU/1/08/448


Mycamine


Norway


17.8.2018




EU/1/08/448


Mycamine


Liechtenstein


31.8.2018




EU/1/08/468


INTELENCE


Iceland


30.8.2018




EU/1/08/468


Intelence


Norway


5.9.2018




EU/1/08/468


Intelence


Liechtenstein


31.8.2018




EU/1/08/473


Evicel


Iceland


30.8.2018




EU/1/08/473


Evicel


Norway


19.9.2018




EU/1/08/473


Evicel


Liechtenstein


31.10.2018




EU/1/08/477


Ceplene


Iceland


28.8.2018




EU/1/08/477


Ceplene


Norway


17.8.2018




EU/1/08/491


Rasilez HCT


Iceland


25.9.2018




EU/1/08/491


Rasilez HCT


Norway


19.9.2018




EU/1/08/499


Valdoxan


Liechtenstein


31.12.2018




EU/1/08/501


Ixiaro


Iceland


7.12.2018




EU/1/08/501


Ixiaro


Norway


17.12.2018




EU/1/08/501


Ixiaro


Liechtenstein


31.12.2018




EU/1/09/508


Synflorix


Iceland


5.12.2018




EU/1/09/508


Synflorix


Norway


5.12.2018




EU/1/09/508


Synflorix


Liechtenstein


31.12.2018




EU/1/12/794


ADCETRIS


Iceland


24.10.2018




EU/1/12/794


Adcetris


Norway


26.9.2018




EU/1/12/794


ADCETRIS


Liechtenstein


31.10.2018




EU/1/13/817


Actelsar HCT


Liechtenstein


31.8.2018




EU/1/13/821


Tolucombi


Liechtenstein


31.8.2018




EU/1/13/823


Adasuve


Liechtenstein


31.8.2018




EU/1/13/824


Nemdatine


Norway


8.8.2018




EU/1/13/824


Nemdatine


Liechtenstein


31.8.2018




EU/1/13/826


Memantine LEK


Norway


21.8.2018




EU/1/13/826


Memantine LEK


Liechtenstein


31.8.2018




EU/1/13/827


Memantine Mylan


Norway


11.10.2018




EU/1/13/827


Memantine Mylan


Liechtenstein


31.8.2018




EU/1/13/828


Hexacima


Norway


17.8.2018




EU/1/13/828


Hexacima


Liechtenstein


31.8.2018




EU/1/13/834


Zoledronic Acid Accord


Iceland


4.12.2018




EU/1/13/834


Zoledronic acid Accord


Norway


30.11.2018




EU/1/13/834


Zoledronic acid Accord


Liechtenstein


31.12.2018




EU/1/13/837


Tecfidera


Iceland


12.10.2018




EU/1/13/837


Tecfidera


Norway


16.10.2018




EU/1/13/837


Tecfidera


Liechtenstein


31.10.2018




EU/1/13/842


Incresync


Norway


3.7.2018




EU/1/13/843


Vipdomet


Norway


3.7.2018




EU/1/13/850


Imnovid


Iceland


26.7.2018




EU/1/13/850


Imnovid


Norway


6.8.2018




EU/1/13/850


Imnovid


Liechtenstein


31.10.2018




EU/1/13/853


Remsima


Norway


6.7.2018




EU/1/13/854


Inflectra


Norway


6.7.2018




EU/1/13/859


Corbilta


Iceland


20.7.2018




EU/1/13/859


Corbilta


Norway


6.8.2018




EU/1/13/860


Nexium Control


Iceland


19.7.2018




EU/1/13/860


Nexium Control


Norway


6.8.2018




EU/1/13/861


Procysbi


Iceland


17.8.2018




EU/1/13/861


Procysbi


Norway


17.8.2018




EU/1/13/861


Procysbi


Liechtenstein


31.8.2018




EU/1/13/869


Lemtrada


Iceland


20.7.2018




EU/1/13/869


Lemtrada


Liechtenstein


31.8.2018




EU/1/13/869


Lemtrada


Norway


6.8.2018




EU/1/13/872


Tybost


Iceland


17.8.2018




EU/1/13/872


Tybost


Norway


21.8.2018




EU/1/13/872


Tybost


Liechtenstein


31.8.2018




EU/1/13/873


Xofigo


Norway


9.7.2018




EU/1/13/877


Grastofil


Iceland


24.10.2018




EU/1/13/877


Grastofil


Norway


12.10.2018




EU/1/13/877


Grastofil


Liechtenstein


31.10.2018




EU/1/13/878


Defitelio


Iceland


9.11.2018




EU/1/13/878


Defitelio


Norway


25.10.2018




EU/1/13/878


Defitelio


Liechtenstein


31.10.2018




EU/1/13/880


Memantin Accord


Norway


21.8.2018




EU/1/13/880


Memantine Accord


Iceland


21.8.2018




EU/1/13/880


Memantine Accord


Liechtenstein


31.8.2018




EU/1/13/881


Fortacin


Iceland


10.10.2018




EU/1/13/881


Fortacin


Norway


16.10.2018




EU/1/13/881


Fortacin


Liechtenstein


31.10.2018




EU/1/13/882


ABILIFY MAINTENA


Iceland


25.9.2018




EU/1/13/882


ABILIFY MAINTENA


Norway


4.9.2018




EU/1/13/882


ABILIFY MAINTENA


Liechtenstein


31.8.2018




EU/1/13/884


Invokana


Iceland


17.8.2018




EU/1/13/884


Invokana


Norway


21.8.2018




EU/1/13/884


Invokana


Liechtenstein


31.8.2018




EU/1/13/885


Kadcyla


Iceland


10.10.2018




EU/1/13/885


Kadcyla


Norway


23.9.2018




EU/1/13/885


Kadcyla


Liechtenstein


31.10.2018




EU/1/13/886


Relvar Ellipta


Iceland


17.8.2018




EU/1/13/886


Relvar Ellipta


Norway


17.8.2018




EU/1/13/886


Relvar Ellipta


Liechtenstein


31.8.2018




EU/1/13/887


Fluenz Tetra


Iceland


4.12.2018




EU/1/13/887


Fluenz Tetra


Norway


18.12.2018




EU/1/13/887


Fluenz Tetra


Liechtenstein


31.12.2018




EU/1/13/888


NovoEight


Iceland


20.8.2018




EU/1/13/888


NovoEight


Norway


30.7.2018




EU/1/13/888


NovoEight


Liechtenstein


31.8.2018




EU/1/13/889


Levetiracetam Hospira


Iceland


30.11.2018




EU/1/13/889


Levetiracetam Hospira


Norway


5.12.2018




EU/1/13/891


Brintellix


Iceland


4.12.2018




EU/1/13/891


Brintellix


Norway


30.11.2018




EU/1/13/891


Brintellix


Liechtenstein


31.12.2018




EU/1/13/892


Tivicay


Iceland


12.10.2018




EU/1/13/892


Tivicay


Norway


16.10.2018




EU/1/13/892


Tivicay


Liechtenstein


31.10.2018




EU/1/13/893


Opsumit


Iceland


28.8.2018




EU/1/13/893


Opsumit


Norway


7.9.2018




EU/1/13/893


Opsumit


Liechtenstein


31.10.2018




EU/1/13/894


Sovaldi


Iceland


10.10.2018




EU/1/13/894


Sovaldi


Norway


16.10.2018




EU/1/13/894


Sovaldi


Liechtenstein


31.10.2018




EU/1/13/900


Xigduo


Iceland


24.10.2018




EU/1/13/900


Xigduo


Norway


16.10.2018




EU/1/13/900


Xigduo


Liechtenstein


31.10.2018




EU/1/13/902


Translarna


Iceland


29.8.2018




EU/1/13/902


Translarna


Norway


1.11.2018




EU/1/13/904


Mirvaso


Iceland


7.12.2018




EU/1/13/904


Mirvaso


Norway


13.12.2018




EU/1/13/904


Mirvaso


Liechtenstein


31.12.2018




EU/1/13/905


IZBA


Norway


6.12.2018




EU/1/13/906


Neuraceq


Iceland


4.12.2018




EU/1/13/906


Neuraceq


Norway


5.12.2018




EU/1/13/906


Neuraceq


Liechtenstein


31.12.2018




EU/1/13/909


Bemfola


Iceland


16.11.2018




EU/1/13/909


Bemfola


Norway


6.12.2018




EU/1/14/913


Latuda


Iceland


30.11.2018




EU/1/14/913


Latuda


Norway


30.11.2018




EU/1/14/929


Revinty Ellipta


Iceland


17.8.2018




EU/1/14/929


Revinty Ellipta


Norway


17.8.2018




EU/1/14/929


Revinty Ellipta


Liechtenstein


31.8.2018




EU/1/15/1078


Natpar


Norway


16.8.2018




EU/1/16/1094


Ninlaro


Iceland


10.10.2018




EU/1/16/1094


Ninlaro


Norway


24.9.2018




EU/1/16/1094


Ninlaro


Liechtenstein


31.10.2018




EU/1/16/1121


Zalmoxis


Iceland


28.8.2018




EU/1/16/1121


Zalmoxis


Norway


1.11.2018




EU/1/16/1138


Venclyxto


Iceland


26.9.2018




EU/1/16/1138


Venclyxto


Norway


14.9.2018




EU/1/16/1138


Venclyxto


Liechtenstein


31.10.2018




EU/1/16/1143


Lartruvo


Iceland


10.10.2018




EU/1/16/1143


Lartruvo


Norway


27.9.2018




EU/1/16/1143


Lartruvo


Liechtenstein


31.10.2018




EU/1/17/1214


Bavencio


Iceland


26.9.2018




EU/1/17/1214


Bavencio


Norway


14.9.2018




EU/1/17/1214


Bavencio


Liechtenstein


31.10.2018




EU/1/13/909


Bemfola


Liechtenstein


31.12.2018




EU/2/08/080


Reconcile


Iceland


26.7.2018




EU/2/08/080


Reconcile


Norway


27.7.2018




EU/2/08/080


Reconcile


Liechtenstein


31.8.2018




EU/2/13/154


Apoquel


Iceland


20.8.2018




EU/2/13/154


Apoquel


Norway


13.8.2018




EU/2/13/154


Apoquel


Liechtenstein


31.8.2018




EU/2/13/156


Vectra 3D


Iceland


25.9.2018




EU/2/13/156


Vectra 3D


Norway


21.9.2018




EU/2/13/157


BROADLINE


Iceland


24.10.2018




EU/2/13/157


Broadline


Norway


16.10.2018




EU/2/13/157


BROADLINE


Liechtenstein


31.10.2018









ANNEX III
List of extended marketing authorisations
The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July–31 December 2018:








EU-Number


Product


Country


Date of authorisation




EU/1/06/363/016


Sprycel


Norway


2.7.2018




EU/1/06/363/016


Sprycel


Iceland


20.7.2018




EU/1/09/521/008


Renvela


Iceland


12.10.2018




EU/1/09/521/008


Renvela


Norway


20.9.2018




EU/1/11/677/007-008


Gilenya


Norway


30.11.2018




EU/1/11/677/007-008


Gilenya


Iceland


5.12.2018




EU/1/11/696/005


Bydureon


Iceland


25.9.2018




EU/1/11/696/005


Bydureon


Norway


27.8.2018




EU/1/14/945/005-012


IMBRUVICA


Iceland


20.7.2018




EU/1/14/952/005


Sevelamer carbonate Zentiva


Iceland


12.10.2018




EU/1/14/952/005


Sevelamer carbonate Zentiva


Norway


20.9.2018




EU/1/15/1046/008-010


Elocta


Norway


7.12.2018




EU/1/16/1132/069-072


Inhixa


Iceland


11.10.2018




EU/1/16/1168


Vihuma


Norway


20.12.2018




EU/1/17/1178/005-009


Xeljanz


Norway


3.9.2018




EU/1/17/1178/005-009


XELJANZ


Iceland


25.9.2018




EU/2/07/078/022-023


Rheumocam


Norway


19.12.2018




EU/2/07/078/022-023


Rheumocam


Iceland


4.12.2018




EU/2/11/134/023-024


Inflacam


Norway


26.11.2018




EU/2/11/134/023-024


Inflacam


Iceland


10.12.2018




EU/2/17/206/016-021


Credelio


Norway


24.9.2018




EU/2/17/206/016-021


Credelio


Iceland


25.7.2018









ANNEX IV
List of withdrawn marketing authorisations
The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July–31 December 2018:








EU-Number


Product


Country


Date of withdrawal




EU/1/01/187


DepoCyte


Iceland


25.7.2018




EU/1/01/187


DepoCyte


Norway


24.7.2018




EU/1/04/283


Ariclaim


Iceland


25.7.2018




EU/1/04/283


Ariclaim


Norway


24.7.2018




EU/1/04/283


Ariclaim


Liechtenstein


31.12.2018




EU/1/04/289


Angiox


Norway


15.8.2018




EU/1/08/505


Intanza


Iceland


27.8.2018




EU/1/08/505


Intanza


Norway


22.8.2018




EU/1/11/681


Trobalt


Iceland


26.7.2018




EU/1/11/681


Trobalt


Norway


15.8.2018




EU/1/11/704


Victrelis


Iceland


19.7.2018




EU/1/11/704


Victrelis


Norway


18.7.2018




EU/1/12/791


Glybera


Iceland


17.7.2018




EU/1/13/908


Eperzan


Iceland


10.12.2018




EU/1/13/908


Eperzan


Norway


11.12.2018




EU/1/14/953


Tasermity


Iceland


17.7.2018




EU/1/15/1017


Taxespira


Iceland


13.11.2018




EU/1/15/1017


Taxespira


Norway


23.11.2018




EU/1/15/1050


IONSYS


Norway


24.10.2018




EU/1/15/1050


IONSYS


Liechtenstein


31.10.2018




EU/1/15/1050


IONSYS


Iceland


25.10.2018




EU/1/16/1145


Ivabradine JensonR


Iceland


11.12.2018




EU/1/16/1145


Ivabradine JensonR


Norway


18.12.2018




EU/1/16/1145


Ivabradine JensonR


Liechtenstein


31.12.2018




EU/1/16/1162


Lusduna


Iceland


19.11.2018




EU/1/16/1162


Lusduna


Norway


29.10.2018




EU/1/16/1163


Solymbic


Iceland


17.7.2018




EU/1/16/1163


Solymbic


Norway


18.7.2018




EU/2/09/102


Gripovac 3


Iceland


28.8.2018




EU/2/09/102


Gripovac 3


Norway


20.9.2018




EU/2/09/102


Gripovac 3


Liechtenstein


31.10.2018




EU/2/13/155


Trifexis


Norway


19.9.2018









ANNEX V
List of suspended marketing authorisations
The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July–31 December 2018:








EU-Number


Product


Country


Date of suspension